What is Soleno Therapeutics Inc?
, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.10B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.